Skip to main content

Table 3 List of the 9 most significant small molecule drugs that can reverse the tumoral status of LSCC

From: Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis

CMap name

Mean

N

Enrichment

P

Specificity

Percent non-null

Thiocolchicoside

− 0.85

4

− 0.837

0.00123

0

100

Gibberellic acid

− 0.714

4

− 0.804

0.00284

0.0107

100

Ciclacillin

− 0.866

4

− 0.786

0.00422

0.0056

100

Cetirizine

− 0.705

4

− 0.781

0.00465

0.0242

100

Medrysone

− 0.7

6

− 0.764

0.00032

0.0108

100

Lomefloxacin

− 0.655

6

− 0.726

0.00085

0

83

Pramocaine

− 0.708

5

− 0.711

0.00435

0

80

Metamizole sodium

− 0.695

6

− 0.657

0.00455

0.0684

83

Tolbutamide

− 0.566

7

− 0.598

0.00643

0

71